Application of Sepsis-3 Criteria to Korean Patients with Critical Illnesses by �굹�꽦�썝
30 https://www.accjournal.org
Jae Yeol Kim1*, Hwan Il Kim2*, Gee Young Suh3, Sang Won Yoon1, Tae-Yop Kim4, Sang Haak Lee5,  
Jae Young Moon6, Jae-Young Kwon7, Sungwon Na8, Ho Geol Ryu9, Jisook Park10, Younsuck Koh11
1Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul; 2Division of Pulmonary and Critical Care Medicine, Department of 
Internal Medicine, Hallym University Medical Center, Anyang; 3Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University 
School of Medicine, Seoul; 4Department of Anesthesiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul; 5Department of 
Internal Medicine, St. Paul’s Hospital, College of Medicine, The Catholic University of Korea, Seoul; 6Division of Pulmonary and Critical Care Medicine,  
Department of Internal Medicine, Chungnam National University Hospital, Daejeon; 7Department of Anesthesia and Pain Medicine, Pusan National  
University School of Medicine, Busan; 8Department of Anesthesia and Pain Medicine, Yonsei University College of Medicine, Seoul; 9Department of  
Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul; 10Department of Software Convergence, Seoul Women’s University, 
Seoul; 11Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Application of Sepsis-3 Criteria to Korean Patients 
with Critical Illnesses
Background: The 2016 Society of Critical Care Medicine (SCCM)/European Society of Inten-
sive Care Medicine (ESICM) task force for Sepsis-3 devised new definitions for sepsis, sepsis 
with organ dysfunction and septic shock. Although Sepsis-3 was data-driven, evidence-based 
approach, East Asian descents comprised minor portions of the project population.     
Methods: We selected Korean participants from the fever and antipyretics in critically ill pa-
tients evaluation (FACE) study, a joint study between Korea and Japan. We calculated the 
concordance rates for sepsis diagnosis between Sepsis-2 and Sepsis-3 criteria and evaluated 
mortality rates of sepsis, sepsis with organ dysfunction, and septic shock by Sepsis-3 criteria 
using the selected data.   
Results: Korean participants of the FACE study were 913 (383 with sepsis and 530 without 
sepsis by Sepsis-2 criteria). The concordance rate for sepsis diagnosis between Sepsis-2 and 
Sepsis-3 criteria was 55.4%. The intensive care unit (ICU) and 28-day mortality rates of sepsis, 
sepsis with organ dysfunction, and septic shock patients according to Sepsis-3 criteria were 
26.2% and 31.0%, 27.5% and 32.5%, and 40.8% and 43.4%, respectively. The quick Sequen-
tial Organ Failure Assessment (qSOFA) was inferior not only to SOFA but also to systemic in-
flammatory response syndrome (SIRS) for predicting ICU and 28-day mortality. 
Conclusions: The concordance rates for sepsis diagnosis between Sepsis-2 and Sepsis-3 crite-
ria were low. Mortality rate for septic shock in Koreans was consistent with estimates made 
by the 2016 SCCM/ESICM task force. SOFA and SIRS were better than qSOFA for predicting 
ICU and 28-day mortality in Korean ICU patients. 
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INTRODUCTION
The definitions of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, 
and septic shock were formulated by consensus during a meeting of the American College of 
Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) in 1991 [1]. Sepsis 
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was defined as SIRS due to infection, presumed or confirmed. 
When sepsis was associated with organ dysfunction, hypo-
perfusion, or hypotension, it was defined as severe sepsis. 
Septic shock was designated as sepsis-induced hypotension 
persisting despite adequate fluid resuscitation.   
 These definitions were revised in 2001 during the Interna-
tional Sepsis Definitions Conference [2]. The 2001 task force 
expanded the lists of diagnostic criteria for SIRS and organ 
dysfunction. However, they did not revise for the definition of 
sepsis due to a lack of supporting evidence. Practically, the 
definitions of sepsis, septic shock, and organ dysfunction have 
remained unchanged for more than two decades.
 Given these circumstances, a task force was appointed by 
the European Society of Intensive Care Medicine (ESICM) 
and the SCCM to prepare new definitions of sepsis. The clini-
cal criteria for sepsis were formulated by a data-driven ap-
proach. The task force performed systematic review and meta-
analysis of sepsis studies, a Delphi study, and cohort studies 
using the Surviving Sepsis Campaign registry [3]. The 2016 
SCCM/ESICM task force introduced a new bedside clinical 
score, quick Sequential Organ Failure Assessment (qSOFA), 
which consists of three parameters (respiratory rate ≥ 22/min, 
altered mentation, and systolic blood pressure [BP] ≤ 100 
mmHg). Patients with at least two of these three clinical vari-
ables are more likely to experience poor outcomes typical of 
sepsis [4]. The term “severe sepsis” was considered to be su-
perfluous and has been discarded. Instead, the Sequential 
(sepsis-related) Organ Failure Assessment (SOFA) was chosen 
to measure organ dysfunction due to reliability and simplicity 
[5]. Organ dysfunction is represented by increase in SOFA 
score of 2 points or more. Septic shock was defined as vaso-
pressor requirement to maintain mean arterial pressure ≥ 65 
mmHg and serum lactate level > 2 mmol/L (18 mg/dl) in the 
absence of hypovolemia. 
 The efforts of the task force that derived and validated the 
Sepsis-3 definitions should be appreciated. Nevertheless, 
there are concerns regarding the Sepsis-3 definitions. Most 
problematically, the health data utilized for the Sepsis-3 were 
almost exclusively derived from the United States and Ger-
many. The primary cohort at the University of Pittsburgh 
Medical Center (UPMC) with suspected infection included 
148,907 encounters. European descents comprised most of 
the cohort (76%), with African-Americans making up the sec-
ond largest group (14%). East Asian descents make up one of 
remaining 10% population. Therefore, generalizability of Sep-
sis-3 definitions to East Asian descents has not been validated. 
 In 2012, the Korean Society of Critical Care Medicine (KSC-
KEY MESSAGES 
■   The concordance rates for sepsis between Sepsis-2 and 
Sepsis-3 criteria were low, which might be associated 
with the weak performance of quick Sequential Organ 
Failure Assessment (qSOFA). 
■   The mortality rate of Korean patients with septic shock 
was consistent with estimates by the 2016 Society of 
Critical Care Medicine/European Society of Intensive 
Care Medicine task force. 
■   Not only SOFA but also systemic inflammatory response 
syndrome (SIRS) was better than qSOFA in predicting 
intensive care unit (ICU) and 28-day mortality in Kore-
an ICU patients.
CM) and the Japanese Society of Intensive Care Medicine 
(JSICM) published a joint study, the fever and antipyretics in 
critically ill patients evaluation (FACE) study which evaluated 
the relationships between fever, antipyretic treatment, and 
mortality in patients admitted to the intensive care unit (ICU) 
[6]. In the FACE study, patients were classified into two groups 
depending on the presence of sepsis at the time of ICU admis-
sion according to Sepsis-2 criteria. We hypothesized that it 
would be possible to evaluate the validity of Sepsis-3 criteria 
and the differential power of Sepsis-3 criteria in Koreans us-
ing of FACE study data. 
MATERIALS AND METHODS
The FACE Study
The FACE study was a binational, multicenter, prospective, 
and observational study to assess the relationship between fe-
ver, antipyretic treatments, and mortality in patients admitted 
to the ICU. It was conducted at 25 hospitals, 10 in Korea and 
15 in Japan. Adult patients who were expected to require in-
tensive care for more than 48 hours were enrolled from Sep-
tember 1, 2009 to November 30, 2009. Patients were classified 
into two groups at the time of ICU admission, those with and 
without sepsis according to Sepsis-2 criteria as judged by at-
tending physicians. Of a total of 1,425 consecutive patients 
(606 with sepsis and 819 without sepsis), we identified 913 
Korean patients to evaluate the utility of Sepsis-3 criteria. 
JSICM, although very interested in this project, did not partici-
pate because of difficulties in obtaining new Institutional Re-
view Board (IRB) approval for using FACE data to evaluate 
Sepsis-3.
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Measurement of Sequential (Sepsis-Related) Organ  
Failure Assessment (SOFA) Score
In the FACE study, severity of disease was evaluated accord-
ing to the Acute Physiology and Chronic Health Evaluation 
(APACHE) II score. APACHE II score does not assess bilirubin 
level or platelet count, which are essential for the measure-
ment of hepatic and hematologic function in SOFA. Therefore, 
we were required to obtain new IRB permission to collect 
these two parameters at each hospital. Nine out of 10 Korean 
hospitals that participated in the FACE study agreed to pro-
ceed after IRB approval for the collection of data regarding 
bilirubin level and platelet count and the use of the FACE data 
set to evaluate the utility of Sepsis-3 criteria. This study was 
approved by IRB of Chung-Ang University Hospital (IRB No. 
1612-008-16023).
Demographics, Clinical Characteristics and Outcomes of 
Korean Patients Enrolled in the FACE Study
Clinical characteristics (route of ICU admission, main reasons 
for ICU care, and comorbidity), therapeutic modalities (use of 
special clinical treatments such as steroids, vasopressor, me-
chanical ventilation, and extracorporeal membrane oxygen-
ation) and clinical outcomes (ICU and 28-day mortality rate) 
were reanalyzed for Korean participants of the FACE study.  
Application of qSOFA, SOFA, and Septic Shock Criteria to 
FACE Study Participants
Patients enrolled in the FACE study were divided into two 
groups, those with and without sepsis according to Sepsis-2 
criteria (more than two SIRS parameters with presumed or 
confirmed infection). We evaluated the concordance rates for 
the diagnosis of sepsis between old and new criteria. Each 
component of the SOFA score (pulmonary, coagulation, he-
patic, circulatory, neurologic, and renal A & B) was calculated 
in patients with and without sepsis. Serum lactate level was 
combined with “persisting hypotension requiring vasopres-
sors to maintain mean arterial pressure ≥ 65 mmHg” to iden-
tify patients whose parameters were compatible with the new 
Sepsis-3 definition of septic shock.    
Mortality Rates of Sepsis, Sepsis with Organ Dysfunction, 
and Septic Shock
Using FACE data, we evaluated the ICU and 28-day mortality 
rates for sepsis, sepsis with organ dysfunction, and septic 
shock by Sepsis-3 criteria. We compared the mortality rates of 
Korean sepsis patients with those included in the UPMC data. 
Statistical Analysis
Continuous variables were presented as mean and standard 
deviation. Categorical data were presented as frequencies and 
percentiles. Intergroup comparisons of demographic and 
safety variables were performed by t-test or Wilcoxon rank 
sum test. Intergroup comparisons of categorical data were 
performed using the chi-square test or Fisher exact test. We 
applied Bonferroni corrections and used them to determine 
whether multiple comparisons of groups were significant. The 
area under the receiver operating characteristic curve (AU-
ROC) was used to evaluate the discriminatory capacity of ICU 
and 28-day mortality among qSOFA, SOFA, and SIRS. We 
considered AUROC to connote poor discrimination at 0.6 to 
0.7, adequate discrimination at 0.7 to 0.8, and good discrimi-
nation at 0.8 to 0.9.
RESULTS
Clinical Characteristics of Korean Participants of the FACE 
Study (with Sepsis Defined by Sepsis-2 Criteria)
Of a total of 913 patients, we identified 383 with and 530 with-
out sepsis. Patients with sepsis were older and more likely to 
be male. More patients were enrolled from the medical ICU 
(MICU) than the surgical ICU (SICU). The main reason for 
MICU care was respiratory problems, while it was cardiovas-
cular problems for SICU care. Over half of MICU patients had 
comorbidities, with malignancy being the most common. Pa-
tients admitted to the SICU had fewer comorbidities than 
those admitted to the MICU. The most common cause of the 
SICU admission was liver cirrhosis (Table 1).       
Treatment Modalities and Clinical Outcomes of Patients 
(with Sepsis Defined by Sepsis-2 Criteria)
Patients with sepsis had received more medical therapies 
such as antipyretics, systemic corticosteroid and vasopressor 
than those without sepsis. A higher proportion of patients 
with sepsis required extra-corporeal membrane oxygenation 
therapy and stayed longer in the ICU compared to those with-
out sepsis. Sepsis patients had higher ICU and 28-day mortal-
ity rates than those without sepsis. Patients with sepsis were 
less likely to be discharged from the hospital or transferred to 
another hospital than patients without sepsis (Table 2).
Application of Sepsis-3 Criteria to Korean Participants of 
the FACE Study
Of 383 patients with sepsis (according to Sepsis-2 criteria), 210 
met at least two of three qSOFA criteria (systolic blood pres-
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Table 1. Clinical characteristics of Korean patients with critical illnesses by Sepsis-2 criteria   
Variable Patient with sepsis Patient without sepsis  P-value 
No. of patients 383 530 -
Age (yr)   66 (53–74)   61 (48–71) <0.001
Male sex 243 (63.4) 300 (56.6) 0.038
Route of ICU admission 
   Surgical ICU (n=328)
      After surgery
      After emergency surgery
   Medical ICU (n=582)
      General ward
      Emergency room
      Other hospital
  
16
 6 (37.5)
10 (62.5)
367
154 (42.0)
203 (55.3)
10 (2.7)
  
312
243 (77.9)
 69 (22.1)
215
 97 (45.1)
112 (52.1)
 6 (2.8)
  
<0.001
  
  
0.051
  
  
  
Main reasons for ICU care 
   Sepsis (n=25)
   Trauma (n=7)
   Malignancy (n=2) 
   Postoperative care (n=114)
   Gastrointestinal (n=81) 
   Renal or metabolic (n=63)
   Respiratory (n=363)
   Cardiovascular (n=198)
   Central nervous (n=23)
   Others (n=32)
  
25 (6.5)
0
 1 (0.3)
 2 (0.5)
23 (6.0)
24 (6.3)
252 (66.0)
17 (4.5)
17 (4.5)
21 (5.5)
  
0
 7 (1.3)
 1 (0.2)
112 (21.1)
 58 (11.0)
 39 (7.4)
 111 (21.1)
 181 (34.4)
  6 (1.1)
 11 (2.1)
  
<0.001
0.024
1.000
<0.001
0.009
0.508
<0.001
<0.001
0.002
0.006
Comorbidity 
   Malignancy
   Liver cirrhosis
   End stage renal disease
   Immunocompromised
   Others
193 (50.4)
126 (65.3)
 29 (15.0)
18 (9.3)
 39 (20.2)
 20 (10.4)
148 (28.0)
 56 (37.8)
 57 (38.5)
 24 (16.2)
 19 (12.8)
 17 (11.5)
<0.001
<0.001
<0.001
0.055
0.073
0.741
Posttransplantation  6 (1.6) 24 (4.5) 0.013
Values are presented as median (range) or number (%).    
ICU: intensive care unit. 
Table 2. Treatments methods and clinical outcomes of Korean patients with critical illnesses by Sepsis-2 criteria
Variable Patient with sepsis Patient without sepsis P-value
No. of patients 383 530 -
Use of antipyretics 180 (47.0) 184 (34.8) <0.001
Use of steroid 183 (47.8) 117 (22.2) <0.001
Use of vasopressor 176 (46.6) 196 (37.8) 0.009
Mechanical ventilationa 245 (64.0) 316 (56.3) 0.183
ECMO (n=123) 72 (18.8) 51 (9.6) <0.001
Duration of ICU stay (n=823)b  5 (3–10)  3 (2–5) <0.001
Readmission to ICU 18 (4.7) 27 (5.1) 0.786
Outcome
   28-Day mortality
   ICU mortality
   Survival in general ward
   Discharge from hospital or transfer to another hospital
  
102 (26.7)
 85 (22.2)
 96 (25.1)
159 (60.9)
  
 63 (12.1)
49 (9.2)
139 (26.6)
301 (82.7)
  
<0.001
<0.001
0.612
<0.001
Values are presented as number (%) or median (range).    
ECMO: extracorporeal membrane oxygenation; ICU: intensive care unit.   
aMechanical ventilation within the first 24 hours during ICU stay; bPatients with sepsis, n=336; Patients without sepsis, n=487.  
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sure ≤ 100 mmHg, altered mentality, or respiratory rate ≥ 22/
min) at the time of ICU admission (55.4%). The positive rate of 
each parameter was 76.2% for systolic BP ≤ 100 mmHg, 63.3% 
for altered mentality, and 88.6% for respiratory rate ≥ 22/min, 
respectively. Meanwhile, 257 of 530 patients (49.1%) without 
sepsis (according to Sepsis-2 criteria) satisfied at least two of 
three qSOFA criteria. The difference between the two groups 
was not statistically significant (P = 0.063). 
 All patients (both with and without sepsis) had SOFA scores 
higher than 2 points at the time of ICU admission. Of 348 sep-
sis patients whose lactate level was available, 98 (28.2%) had 
lactate level > 2 mmol/L and they had hypotension which re-
quired vasopressor therapy to maintain mean arterial pres-
sure ≥ 65 mmHg. Meanwhile, 20.1% of non-sepsis patients 
met new Sepsis-3 septic shock criteria. The difference be-
tween the two groups was statistically significant (P < 0.01) 
(Table 3).
Mortality Rates of Sepsis, Sepsis with Organ Dysfunction, 
and Septic Shock Patients (Classified by Sepsis-3 Criteria)
The overall ICU and 28-day mortalities of Korean patients en-
rolled for FACE study were 14.7% and 18.1%, respectively. The 
ICU and 28-day mortality rates of sepsis, sepsis with organ 
dysfunction, and septic shock patients according to Sepsis-3 
definitions were 26.2% and 31.0%, 27.5% and 32.5%, and 
40.8% and 43.4%, respectively (Figure 1). 
Discriminatory Capacity of qSOFA, SOFA, and SIRS for ICU 
and 28-Day Mortality in Sepsis Patients 
AUROCs for discriminatory capacity for ICU and 28-day mor-
tality showed that qSOFA was inferior not only to SOFA but 
also to SIRS in predicting both parameters (Figure 2). 
DISCUSSION
Sepsis is a clinical syndrome that comprises physiologic, bio-
Table 3. Application of Sepsis-3 criteria to Korean patients with critical illnesses   
Variable Patient with sepsis Patient without sepsis P-value
No. of patients 383 530 -
qSOFA score
   Systolic BP ≤100 mmHg
   Altered mentality 
   Respiratory rate ≥22/min
   qSOFA ≥2
  
184 (48.7)
164 (43.4)
254 (67.2)
210 (55.4)
  
149 (28.8)
202 (61.0)
294 (57.3)
257 (49.1)
  
<0.001
<0.001
0.003
0.063
SOFA score
   Pulmonary
   Coagulation
   Hepatic
   Circulatory
   Neurologic
   Renal A
   Renal B
   Total score
  
2 (1–3)
1 (0–2)
0 (0–1)
1 (0–4)
1 (0–2)
1 (0–2)
0
9 (5–11)
  
2 (1–3)
1 (0–2)
0 (0–2)
1 (0–3)
0 (0–2)
0 (0–1)
0
7 (5–10)
  
0.428
0.385
0.065
0.009
0.012
<0.001
0.250
0.001
Septic shock
   Persisting hypotension requiring vasopressors (n=372)
   Lactate >2 mmol/L (n=329)
   Both (total n=771)
  
176 (46.6)
141 (40.5)
98/348 (28.1)
  
196 (37.8)
188 (44.4)
85/423 (20.1)
  
0.009
0.273
0.009
Values are presented as number (%) or median (range).    
qSOFA: quick Sequential Organ Failure Assessment; BP: blood pressure. 
Figure 1. Mortality rates of all patients, patients with sepsis, pa-
tients with sepsis and organ dysfunction, and septic shock patients 
(classified by Sepsis-3 criteria) in Korean patients with critical ill-
nesses who participated in the fever and antipyretics in critically 
ill patients evaluation study. ICU: intensive care unit.
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logic, and biochemical abnormalities caused by inflammatory 
responses to invading microorganisms. The first international 
consensus conference in 1991 and subsequent revision in 
2001 relied mainly on expert opinion to generate a clinical 
definition of sepsis [2,7]. Advances in the understanding of 
the pathophysiology of sepsis and the increasing availability 
of large electronic health record data sets, registries, and trial 
data sets enabled the application of an evidence-based ap-
proach to formulate new definitions of sepsis and septic 
shock. However, the lack of regional diversity among the pa-
tient sample upon which the Sepsis-3 criteria are based in-
spired us to evaluate the utility of these new sepsis definitions 
using data collected for the FACE study data. 
 The FACE study was a binational study performed in Korea 
and Japan, where most of population are East Asian descents. 
For the present study, we selected Korean participants of the 
FACE study. In the FACE study, patients were identified as 
with or without sepsis according to Sepsis-2 criteria at the 
time of ICU admission, which allowed us to figure out easily 
which patients harbored infection at the time of ICU admis-
sion [6]. 
 The 2016 SCCM/ESICM task force for Sepsis-3 developed 
qSOFA, as a way to facilitate the identification of patients po-
tentially at risk of dying from sepsis. The qSOFA score is easy 
to calculate since it has only three components (respiratory 
rate ≥ 22/min, altered mentation, and systolic BP ≤ 100 
mmHg). A qSOFA score ≥ 2 is associated with poor outcomes 
due to sepsis. The qSOFA score was originally recommended 
as for assessment of patients outside the ICU [3-5]. It has since 
been prospectively studied in several settings including the 
emergency department (ED) and ICU with conflicting results. 
In a 2018 meta-analysis of 38 studies that included patients 
from the ED, wards, and ICU, qSOFA showed poor sensitivity 
compared to SIRS for predicting mortality from sepsis [8]. In 
addition, a retrospective analysis of 184,875 ICU patients with 
infection-related admission reported that qSOFA was inferior 
to SOFA for predicting in-hospital mortality [9]. These find-
ings are consistent with the results of the present study. We 
did not detect statistically significant differences between pa-
tients with or without sepsis by Sepsis-2 criteria with qSOFA 
score ≥ 2 criterion (55.4% vs. 49.1%) (Table 3). qSOFA was 
originally developed as an assessment tool for patients out-
side the ICU. Because FACE study exclusively included pa-
tients who were expected to stay in the ICU for more than 48 
hours, the weak performance of qSOFA in the present study is 
not surprising. In addition, the AUROC of discriminatory ca-
pacity for ICU and 28-day mortality showed that qSOFA score 
was inferior not only to SOFA and but also to SIRS in predict-
ing both parameters (Figure 2). qSOFA may therefore not be 
as robust as originally anticipated. Among the three parame-
ters comprising qSOFA, “altered mentality” showed the low-
est positive rate in sepsis patients who met both Sepsis-2 and 
Sepsis-3 definition criteria. All things considered, clinicians 
should keep in mind that qSOFA was originally designed not 
as a diagnostic tool but rather as a predictive tool that calcu-
lates the risk of death from sepsis. 
 The term “severe sepsis,” which describes sepsis with tissue 
hypoperfusion and/or organ dysfunction, is no longer in use 
Figure 2. Area under the receiver operating characteristic curves (AUROCs) for discriminatory capacity for 28-day mortality and ICU mor-
tality. (A) Twenty-eight–day mortality. AUROC: SOFA, 0.74 (95% CI, 0.68 to 0.79); qSOFA, 0.59 (95% CI, 0.53 to 0.66); SIRS, 0.60 (95% CI, 
0.54 to 0.66). (B) ICU mortality. AUROC: SOFA, 0.74 (95% CI, 0.68 to 081); qSOFA, 0.59 (95% CI, 0.52 to 0.66); SIRS, 0.63 (95% CI, 0.57 to 
0.70). SOFA: Sequential Organ Failure Assessment; qSOFA: quick SOFA; SIRS: systemic inflammatory response syndrome; CI: confidence in-
terval; ICU: intensive care unit.
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in Sepsis-3 [2]. Instead, organ dysfunction is defined as an in-
crease of two or more points in the SOFA score. Patients who 
fulfill these criteria have a predicted mortality of 10% or more. 
All patients enrolled in the FACE study satisfied the criterion of 
SOFA score greater than 2 points. The median values of SOFA 
in the with-sepsis and without-sepsis groups were 9 and 7, re-
spectively (Table 3). This finding implies that FACE patients 
are characterized by high degree of organ dysfunction, which 
might in turn explain the higher ICU and 28-day mortality 
rates of sepsis patients (26.2% and 31.0%) and sepsis with or-
gan dysfunction (27.5% and 32.5%). Septic shock patients had 
ICU and 28-day mortality rates of 40.8% and 43.4%, respective-
ly (Figure 1). This is consistent with the estimates by the 2016 
SCCM/ESICM task force. In their analysis, the mortality rate of 
septic shock patients was greater than 40% [10,11]. 
 A limited number of studies evaluated the mortality rates of 
patients with sepsis using large samples of Korean patients. In 
a prospective, multicenter, observation study that included 
1,192 adult patients admitted to 22 participating ICUs of 12 
university hospitals in Korea, the 28-day mortality rate was 
23.0% according to Sepsis-2 septic shock criteria [12]. The new 
Sepsis-3 definition of septic shock estimates 40% of mortality 
rate among septic shock patients, therefore, new definition 
may represent more severe disease than the previous defini-
tion. Another observational, prospective, multi-center registry 
study performed by 10 EDs at tertiary hospitals in Korea found 
that the 28-day mortality rate of septic shock patients defined 
according to Sepsis-3 criteria was 25.1%, which is far lower 
than the mortality rate observed in the present study and that 
observed by the 2016 SCCM/ESICM task force [13]. To our 
best knowledge, this is the first study to present data regarding 
the mortality rates of patients with sepsis, sepsis with organ 
dysfunction, and septic shock as defined by Sepsis-3 criteria 
using a large sample of Korean ICU patients. 
 In conclusion, the concordance rates for sepsis between 
Sepsis-2 and Sepsis-3 criteria were low, which might be asso-
ciated with the weak performance of qSOFA. The mortality 
rate of Korean patients with septic shock was consistent with 
estimates by the 2016 SCCM/ESICM task force. Not only 
SOFA but also SIRS was better than qSOFA in predicting ICU 
and 28-day mortality in Korean ICU patients.
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